Literature DB >> 9558389

High CD30 ligand expression by epithelial cells and Hassal's corpuscles in the medulla of human thymus.

P Romagnani1, F Annunziato, R Manetti, C Mavilia, L Lasagni, C Manuelli, G B Vannelli, V Vanini, E Maggi, C Pupilli, S Romagnani.   

Abstract

CD30 is a member of tumor necrosis factor (TNF) receptor superfamily that is expressed by activated T cells in the presence of interleukin-4 (IL-4). Although CD30 can mediate a variety of signals, CD30-deficient mice have impaired negative selection of T cells, suggesting that at least in the context of murine thymus, CD30 is a cell death-mediating molecule. The ligand for CD30 (CD30L) is a membrane-associated glycoprotein related to TNF, which is known to be expressed mainly by activated T cells and other leukocytes. However, the nature of CD30L-expressing cells involved in the interaction with CD30+ thymocytes is unclear. We report here that in postnatal human thymus the great majority of CD30+ cells are double positive (CD4+CD8+), activated, IL-4 receptor-expressing T cells which selectively localize in the medullary areas. Moreover, many medullary epithelial cells and Hassal's corpuscles in the same thymus specimens showed unusually high expression of CD30L in comparison with other lymphoid or nonlymphoid tissues. These findings provide additional information on the nature and localization of CD30+ thymocytes and show that epithelial cells are the major holder of CD30L in the thymic medulla.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9558389

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Regulation of CD30 antigen expression and its potential significance for human disease.

Authors:  M E Kadin
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Thymocyte apoptosis.

Authors:  Y Yang; J D Ashwell
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

Review 3.  TSLP and immune homeostasis.

Authors:  Shino Hanabuchi; Norihiko Watanabe; Yong-Jun Liu
Journal:  Allergol Int       Date:  2012-01-25       Impact factor: 5.836

4.  Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.

Authors:  Robert Zeiser; Vu H Nguyen; Jing-Zhou Hou; Andreas Beilhack; Elizabeth Zambricki; Martin Buess; Christopher H Contag; Robert S Negrin
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

5.  Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity.

Authors:  P Romagnani; F Annunziato; L Lasagni; E Lazzeri; C Beltrame; M Francalanci; M Uguccioni; G Galli; L Cosmi; L Maurenzig; M Baggiolini; E Maggi; S Romagnani; M Serio
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 6.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 7.  TNF superfamily: costimulation and clinical applications.

Authors:  Dass S Vinay; Byoung S Kwon
Journal:  Cell Biol Int       Date:  2009-02-20       Impact factor: 3.612

8.  Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

Authors:  Christos Vaklavas; Andres Forero-Torres
Journal:  Ther Adv Hematol       Date:  2012-08

9.  Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.

Authors:  Juan Pedro Kusanovic; Roberto Romero; Sonia S Hassan; Francesca Gotsch; Samuel Edwin; Tinnakorn Chaiworapongsa; Offer Erez; Pooja Mittal; Shali Mazaki-Tovi; Eleazar Soto; Nandor Gabor Than; Lara A Friel; Bo Hyun Yoon; Jimmy Espinoza
Journal:  J Matern Fetal Neonatal Med       Date:  2007-12

10.  TGF-β type II receptor expression in thymic epithelial cells inhibits the development of Hassall's corpuscles in mice.

Authors:  Chikako Odaka; Mathias Hauri-Hohl; Kazuya Takizawa; Yomiko Nishikawa; Masashi Yano; Mitsuru Matsumoto; Richard Boyd; Georg A Holländer
Journal:  Int Immunol       Date:  2013-08-08       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.